Press release
Non-invasive Ventilation (NIV) Helmets Market Size, Sales, Average Price and Trends Analysis, till 2032
Non-invasive Ventilation (NIV) Helmets Market Size is estimated to be $198million in 2024 and is expected to grow at an average yearly rate of around 5.6% during the timeframe (2025-2032).Monitor Country-wise Non-invasive Ventilation (NIV) Helmets Sales and Demand with Our Comprehensive Non-invasive Ventilation (NIV) Helmets Sales Database
Gain in-depth insights into the Non-invasive Ventilation (NIV) Helmets Sales landscape across 20+ countries with our specialized Non-invasive Ventilation (NIV) Helmets Sales Database. Stay ahead in the market by tracking country-wise Non-invasive Ventilation (NIV) Helmets Sales, identifying key manufacturers.
Extensive Non-invasive Ventilation (NIV) Helmets Sales database covering 20+ countries worldwide, Non-invasive Ventilation (NIV) Helmets Sales trends
Non-invasive Ventilation (NIV) Helmets market revenue tracker by country
Stay Updated with Non-invasive Ventilation (NIV) Helmets Sales Trends
Track real-time Non-invasive Ventilation (NIV) Helmets prices, analyze Non-invasive Ventilation (NIV) Helmets price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.
The research and analytics firm Datavagyanik released the updated version of its report on "Non-invasive Ventilation (NIV) Helmets Market - Detailed Analysis, Business Opportunities and Forecasts".
Request sample at https://datavagyanik.com/reports/non-invasive-ventilation-niv-helmets-market/
Non-invasive Ventilation (NIV) Helmets sales trend in 2024 vs 2025
Non-Invasive Ventilation (NIV) helmets are increasingly becoming a preferred method for delivering respiratory support in both hospital and home-care settings. Unlike traditional face masks, these helmets fully enclose the patient's head, minimizing air leaks and reducing the risk of aerosol dispersion - a particularly important feature during infectious outbreaks. The sales trends of these devices have shown a dynamic shift from 2024 to 2025, influenced by evolving healthcare demands, innovation, and greater acceptance among healthcare professionals.
Market Performance in 2024
In 2024, the demand for NIV helmets was on the rise, driven largely by the continued emphasis on non-invasive respiratory care following lessons from recent global health crises. Hospitals and intensive care units saw increased use of these devices, especially in managing conditions such as COPD, pneumonia, and early-stage respiratory failure. Although not yet ubiquitous, NIV helmets started gaining broader acceptance in regions with robust healthcare infrastructures, particularly in Europe and North America.
During this period, market growth was steady. Hospitals began to view NIV helmets as a long-term investment due to their reusability and effectiveness. Furthermore, a moderate rise in home-care ventilatory support also contributed to market traction. However, widespread adoption was still limited by factors such as cost, lack of awareness in developing regions, and resistance from practitioners unfamiliar with the technology.
Projected Sales and Growth in 2025
In 2025, the sales of NIV helmets are expected to grow more significantly. This growth is fueled by several converging factors. Firstly, there is an ongoing shift towards less invasive treatment options. NIV helmets provide a patient-friendly alternative that reduces the need for sedation and intubation, making them more desirable from both a clinical and economic perspective.
Secondly, manufacturers have made considerable improvements in the design and usability of these helmets. Modern versions are more comfortable, less noisy, and easier to handle, which addresses some of the earlier concerns expressed by healthcare staff and patients. As a result, there has been a noticeable increase in procurement not just by hospitals but also by long-term care facilities and home healthcare providers.
Furthermore, training programs and clinical guidelines have been updated to include NIV helmets as standard non-invasive ventilation tools. This formal inclusion has encouraged more hospitals to adopt them. Additionally, developing countries are beginning to explore these technologies due to international healthcare aid and growing awareness of their benefits.
Comparative Insights: 2024 vs. 2025
The most striking difference between 2024 and 2025 is the rate of adoption and geographical expansion. While 2024 saw a steady increase in sales mostly confined to high-income regions, 2025 is witnessing a broader global distribution. The market in 2025 is also more diversified, with both public hospitals and private home-care services purchasing NIV helmets in greater volumes.
Request for customization https://datavagyanik.com/reports/non-invasive-ventilation-niv-helmets-market/
Non-invasive Ventilation (NIV) Helmets Market Definition
Non-Invasive Ventilation (NIV) helmets are medical devices designed to provide respiratory support without the need for intubation or invasive procedures. These helmets form a sealed environment around the patient's head and deliver continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP) using an external ventilator. The market for NIV helmets is a specialized segment within the broader respiratory care and non-invasive ventilation equipment industry.
Understanding the Role of NIV Helmets
NIV helmets serve a critical function in respiratory therapy, especially for patients suffering from acute or chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), pneumonia, COVID-19, and other forms of respiratory failure. Unlike traditional face masks, NIV helmets offer a full head enclosure with a transparent hood made of soft, medical-grade plastic. This enclosure reduces air leakage and significantly lowers the risk of aerosol transmission - a key advantage during infectious outbreaks.
These helmets are used in both hospital intensive care units (ICUs) and home-care settings. Their non-invasive nature makes them a preferred option for patients who are conscious and able to breathe spontaneously but need respiratory support to improve oxygen intake or reduce the effort of breathing. The design allows patients to talk, eat soft food, and drink liquids while receiving therapy, which significantly enhances comfort and compliance.
Market Components and Structure
The NIV helmet market includes several key components and stakeholders:
Manufacturers: Companies that design and produce helmets, often in compliance with international medical device regulations.
Distributors and Suppliers: Entities that manage logistics and deliver products to healthcare facilities.
Hospitals and Clinics: Primary users of NIV helmets in acute care and emergency settings.
Home Healthcare Providers: Secondary users who adopt these devices for managing long-term respiratory conditions at home.
End Users: Patients with respiratory ailments who benefit directly from the use of these helmets.
The market also comprises related accessories such as sealing collars, neck cushions, and air flow circuits that support the use of helmets.
Key Market Drivers
The demand for NIV helmets is primarily driven by the increasing global incidence of respiratory disorders, advancements in non-invasive ventilation technology, and the shift toward patient-centered care. The COVID-19 pandemic played a significant role in bringing attention to the benefits of NIV helmets, especially for their ability to reduce the spread of airborne pathogens while maintaining effective respiratory support.
Additionally, the rise in aging populations worldwide and a growing preference for home-based healthcare solutions are contributing to sustained market growth. Training programs, medical guidelines, and increased healthcare funding are further enhancing the adoption of these devices.
Market Segmentation
The market can be segmented based on:
End Use: Hospitals, emergency departments, ICUs, and home healthcare.
Geography: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Type of Ventilation: CPAP-based helmets, BiPAP-compatible helmets, and high-flow oxygen helmets.
Important target segments driving the demand for Non-invasive Ventilation (NIV) Helmets Market
The market for Non-Invasive Ventilation (NIV) helmets has grown substantially over recent years, driven by increased awareness of non-invasive respiratory support methods and their advantages over traditional ventilation. The demand is primarily fueled by several important target segments across the healthcare landscape. These segments reflect a mix of clinical need, demographic trends, and evolving care settings. Understanding these groups helps clarify the direction of market growth and innovation.
1. Hospitals and Intensive Care Units (ICUs)
One of the largest and most influential segments driving demand for NIV helmets is hospitals, especially their ICU departments. Patients in ICUs with conditions like acute respiratory distress syndrome (ARDS), pneumonia, COPD exacerbations, and even COVID-19 are frequently managed using non-invasive methods before intubation becomes necessary. NIV helmets offer an effective alternative that reduces the need for sedation and invasive procedures. Their ability to provide sealed, controlled ventilation while allowing patient communication makes them especially valuable in critical care settings. As hospitals aim to improve patient outcomes and reduce complications, the adoption of NIV helmets is expected to grow.
2. Emergency and Acute Care Units
Another critical segment includes emergency departments and acute care units. These environments often deal with sudden-onset respiratory conditions that require immediate intervention. NIV helmets provide a rapid, non-invasive solution that can stabilize patients in respiratory distress. Their ease of application and ability to prevent the spread of aerosols also make them suitable for use in high-risk, high-traffic areas like emergency rooms. Their value in these settings was particularly evident during the COVID-19 pandemic, and this has led to long-term changes in respiratory support protocols.
3. Home Healthcare and Long-Term Care Facilities
The growing trend of shifting care from hospitals to home or long-term care environments has created new opportunities for NIV helmet usage. Patients with chronic respiratory conditions such as COPD, sleep apnea, or neuromuscular diseases benefit greatly from long-term non-invasive ventilation. NIV helmets are increasingly being adopted in these settings due to their comfort, safety, and suitability for prolonged use. Additionally, the development of portable and user-friendly helmet systems supports home-based therapy, allowing patients to manage their conditions with minimal hospital visits.
4. Geriatric Population
The aging population represents a significant driver of demand for NIV helmets. Elderly individuals are more prone to chronic respiratory diseases, weakened lung function, and comorbidities that complicate invasive treatments. NIV helmets provide a gentler, safer alternative to traditional mechanical ventilation, which may carry higher risks for older adults. The ability to deliver non-invasive therapy effectively, without exposing frail patients to unnecessary trauma, is a key reason for their growing use in geriatric care.
5. Patients with Infectious Respiratory Diseases
Finally, patients suffering from infectious respiratory diseases form an increasingly important segment. NIV helmets provide a closed ventilation system that minimizes air leakage and reduces the spread of infectious aerosols. This feature is crucial not only in hospitals but also in temporary care units and isolation centers. The COVID-19 pandemic underscored the value of such systems, and awareness has since remained high, influencing purchasing decisions in both public and private healthcare sectors.
Key Players in Non-invasive Ventilation (NIV) Helmets, Market Share
The Non-Invasive Ventilation (NIV) helmets market is part of the broader respiratory care industry and includes a mix of global medical device giants and specialized manufacturers. These key players have contributed significantly to the development and commercialization of NIV helmets, especially as demand rises due to chronic respiratory diseases, aging populations, and the focus on non-invasive treatment methods. The competitive landscape is shaped by innovation, distribution strength, product reliability, and responsiveness to global healthcare challenges.
1. ResMed Inc.
ResMed is a dominant force in the respiratory care industry, widely recognized for its comprehensive range of ventilatory support products. Though traditionally known for sleep apnea devices and CPAP machines, ResMed has diversified into non-invasive ventilation, including helmet-based systems. Its strong R&D capabilities and global distribution have allowed it to gain a solid foothold in the NIV helmet market, particularly in North America and Europe. The company's strategy focuses on digital integration and cloud-based patient monitoring, which enhances the usability of its non-invasive devices.
2. Philips Healthcare
Philips Healthcare holds a significant share of the NIV helmet market due to its wide-ranging respiratory care solutions and brand credibility. The company has been active in advancing non-invasive therapy options, particularly in intensive care and home-care environments. Philips' NIV helmets are often praised for their ergonomic design and ease of use. Its large-scale presence in hospitals and partnerships with healthcare systems globally have strengthened its market position. Additionally, Philips leverages its extensive after-sales support and training services to maintain customer loyalty.
3. Fisher & Paykel Healthcare
Based in New Zealand, Fisher & Paykel Healthcare has carved a strong niche in respiratory care through innovation in humidification systems and non-invasive ventilation interfaces. The company is particularly known for its focus on patient comfort, an area where NIV helmets excel over traditional masks. Fisher & Paykel's continuous product development and evidence-based approach have enabled it to gain increasing market share in Asia-Pacific and Latin American markets, in addition to its presence in developed countries.
4. Drägerwerk AG & Co. KGaA
Dräger, a German-based company, is a long-standing player in critical care equipment, including ventilators and oxygen therapy devices. In the NIV helmet space, Dräger is recognized for its safety-focused design and technical reliability, especially in hospital environments. The company offers specialized helmets for neonatal and pediatric use, giving it an edge in those sub-segments. Dräger's reputation for clinical-grade quality and strong customer relationships in Europe contribute to its stable market share.
5. Hamilton Medical
Hamilton Medical focuses on intelligent ventilation systems and has introduced several products that support NIV helmet compatibility. The company's emphasis on automation, patient monitoring, and adaptive algorithms enhances the performance of NIV helmets used in both acute and long-term care. Though smaller in size compared to industry giants, Hamilton has built a solid reputation for innovation, particularly in high-acuity settings like ICUs.
Key Questions Answered in the Non-invasive Ventilation (NIV) Helmets market report:
What is the total global Non-invasive Ventilation (NIV) Helmets Sales volume, and how has it changed over the past five years?
What is Non-invasive Ventilation (NIV) Helmets price trend, what has been the historical prices?
What will be the Non-invasive Ventilation (NIV) Helmets price trend in 2025?
Which countries have the highest Non-invasive Ventilation (NIV) Helmets Sales, and what factors contribute to their dominance in the market?
How does Non-invasive Ventilation (NIV) Helmets Sales vary across key manufacturers, and what expansions have been observed recently?
What is the current global revenue generated from Non-invasive Ventilation (NIV) Helmets Sales, and how does it compare to previous years?
Which industries drive the highest demand for Non-invasive Ventilation (NIV) Helmets, and how is this demand expected to evolve in the next five years?
What are the major challenges impacting Non-invasive Ventilation (NIV) Helmets Sales and supply chain operations across key markets?
How do government policies, environmental regulations, and trade restrictions affect Non-invasive Ventilation (NIV) Helmets Sales and market dynamics?
Related Studies:
Tissue Contact Probe Ablators Market
https://datavagyanik.com/reports/tissue-contact-probe-ablators-market/
PVA Embolization Particles Market
https://datavagyanik.com/reports/pva-embolization-particles-market/
Microwave Tumor Ablation System Market
https://datavagyanik.com/reports/microwave-tumor-ablation-system-market/
Phrenic Nerve Stimulation Devices Market
https://datavagyanik.com/reports/phrenic-nerve-stimulation-devices-market/
Argon Plasma Coagulator Market
https://datavagyanik.com/reports/argon-plasma-coagulator-market/
IT Park, Dehradun, UK
Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.
Contact us:
Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/Email: sales@datavagyanik.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-invasive Ventilation (NIV) Helmets Market Size, Sales, Average Price and Trends Analysis, till 2032 here
News-ID: 4008073 • Views: …
More Releases from Datavagyanik Business Intelligence

Beta-Sitosterol Supplements Market Size, Clinical Trials, Product Pipelines and …
Beta-Sitosterol Supplements Market Size is estimated to be $670 million in 2024 and is expected to grow at an average yearly rate of around 9% during the timeframe (2025-2032).
What is Beta-Sitosterol Supplements and what are the growth drivers of Beta-Sitosterol Supplements Market?
Beta-sitosterol is a naturally occurring plant sterol found in fruits, vegetables, nuts, and seeds. Structurally similar to cholesterol, it competes with dietary cholesterol…

Cranberry-based Supplements Market Size, Clinical Trials, Product Pipelines and …
Cranberry-based Supplements Market Size is estimated to be $1040 million in 2024 and is expected to grow at an average yearly rate of around 8% during the timeframe (2025-2032).
What is Cranberry-based Supplements and what are the growth drivers of Cranberry-based Supplements Market?
Cranberry-based supplements are dietary products formulated from cranberry fruit-most commonly Vaccinium macrocarpon-available in various forms such as tablets, capsules, powders, and liquid extracts. These supplements either contain…

Lipase Inhibitors Market Size, Clinical Trials, Product Pipelines and Investment …
Lipase Inhibitors Market Size is estimated to be $945 million in 2024 and is expected to grow at an average yearly rate of around 6% during the timeframe (2025-2032).
What is Lipase Inhibitors and what are the growth drivers of Lipase Inhibitors Market?
Lipase inhibitors are compounds that block the activity of lipase, an enzyme responsible for breaking down dietary fats in the digestive system. By inhibiting lipase, these substances…

Tricyclic Antidepressants Market Size, Clinical Trials, Product Pipelines and In …
Tricyclic Antidepressants Market Size is estimated to be $4950 million in 2024 and is expected to grow at an average yearly rate of around 7% during the timeframe (2025-2032).
What is Tricyclic Antidepressants and what are the growth drivers of Tricyclic Antidepressants Market?
Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat major depressive disorder. They are among the earliest forms of antidepressants…
More Releases for NIV
Nipah Virus (Niv) Infection Testing Market Size and Growth Forecast by Applicati …
USA, New Jersey- According to Market Research Intellect, the global Nipah Virus (Niv) Infection Testing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Due to the growing threat posed by NiV outbreaks and the increasing demand for prompt and precise diagnostic solutions, the market for…
Nipah Virus (Niv) Infection Testing Market Size and Growth Forecast by Applicati …
USA, New Jersey- According to Market Research Intellect, the global Nipah Virus (Niv) Infection Testing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The Nipah Virus (NiV) infection testing market is witnessing notable growth due to the increasing awareness and concerns surrounding viral outbreaks. As…
Nipah Virus (NiV) Infection Testing Market to hit US$ 2.97 Billion by 2031: Grow …
Newark, New Castle, USA - Nipah Virus (NiV) Infection Testing Market Analysis 2023 | Business Opportunities, Pricing Strategy, Forthcoming opportunities planning, Market-specific challenges, Globally Market Key Facts are coverd in this report by Growth Plus Reports | 100+ Report Pages
Nipah Virus (NiV) Infection Testing Market 2023 with 100+ Pages Report and enhance with extents shares into sub-counties are covered in this market. Nipah Virus (NiV) Infection Testing Market conditions can…
2030 Projections: Nipah Virus (NiV) Infection Testing Market to Deliver Dynamic …
Nipah Virus (NiV) Infection Testing Market Report Forecast to 2023-2030 provides deep market insights to assist firms in making better business decisions and driving growth plans, based on prediction and market trends. The dynamic market structure, key players product offerings, their challenges, technical innovation, obstacles and barriers, information on communication and sales, sales by nation, risk, prospects, competitive landscape, growth strategy, and so on are all marketing variables covered in…
Sleep Non-invasive Ventilator (NIV) Market 2021: Global Size, Supply-Demand, Pro …
"Market Summary
A newly published report titled “(Sleep Non-invasive Ventilator (NIV) Market)” by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario, market entry strategies, best industry practices, pricing strategy, technology…
Medical Non-invasive Ventilator (NIV) Market to Witness Huge Growth by 2026| Key …
ReportsnReports.com the exclusive leading provider of market research reports published research report on "Global Medical Non-invasive Ventilator (NIV) Market Research Report 2020".
The Global Medical Non-invasive Ventilator (NIV) Market Report 2020 is a professional and in-depth study on the current state of the Medical Non-invasive Ventilator (NIV) Market.
This report focuses on Medical Non-invasive Ventilator (NIV) volume and value at global level, regional level and company level. From a global perspective, this…